A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers
Clinical trial NCT06481202 · COMPLETED
Trial details
- NCT number
- NCT06481202
- Sponsor
- AO GENERIUM
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2022-06-14
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.